FAQs

Ask if AREXVY is right for you

FAQs

Ask if AREXVY is right for you

Questions to Ask Your Doctor or Pharmacist

  • Should I be concerned about respiratory syncytial virus (RSV)?
  • How could RSV impact me if I have asthma, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), coronary artery disease (CAD), diabetes, or neurologic or neuromuscular disorders?
  • Should I get vaccinated against RSV?
  • Is vaccination with AREXVY right for me?
  • How effective is vaccination with AREXVY?
  • What are the side effects of AREXVY?
  • When and where can I get vaccinated with AREXVY?

Find pharmacies near you that offer AREXVY

GET AREXVY

AREXVY FAQs

Collapse AllExpand All

  • What is AREXVY?

    AREXVY is an FDA-approved vaccine for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in:

    • people 60 years of age and older;
    • people 18 through 59 years of age at increased risk for LRTD caused by RSV

     

    AREXVY is not for use in pregnant people.

  • Why should someone who is 60+ years or who is 18-59 years at increased risk for severe RSV consider getting AREXVY?

    AREXVY was proven effective in a large study with people 60+ years.

    • Over 82% EFFECTIVE in preventing lower respiratory tract disease from RSV in people aged 60 years and older
    • Over 94% EFFECTIVE in preventing lower respiratory tract disease from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), advanced liver or kidney disease, or any chronic respiratory/pulmonary disease

    Effectiveness in adults 18-59 at increased risk* was based on the immune responses compared to that seen in adults 60+.

    *Increased risk includes individuals 18 through 59 years of age with conditions like respiratory disease, cardiovascular disease, liver disease, kidney disease, diabetes, and for individuals 18 through 49 years of age, neurological or neuromuscular conditions.

  • Who can get AREXVY?

    AREXVY is available for people 60+ years and those 18-59 years at increased risk* for RSV.

    AREXVY is not for use in pregnant people.

    *Increased risk includes individuals 18 through 59 years of age with conditions like respiratory disease, cardiovascular disease, liver disease, kidney disease, diabetes, and for individuals 18 through 49 years of age, neurological or neuromuscular conditions.

  • How is AREXVY given?

    AREXVY is a single-dose injection (or “shot”) given in the upper arm.

  • What are the most common side effects of AREXVY?

    The most common side effects of AREXVY are:

    • Pain, redness, and swelling at injection site
    • Fatigue
    • Muscle pain
    • Headache
    • Joint pain

  • Is vaccination with AREXVY covered by insurance?

    The cost of vaccination with AREXVY depends on your age and the type of insurance you have. Ask your doctor or pharmacist if AREXVY is covered. If you need cost information, visit GSKforyou.com or call 1-866-GSK-FOR-U.

Have more questions about the vaccine?

ABOUT AREXVY

RSV FAQs

Collapse AllExpand All

Have more questions about the virus?

ABOUT RSV

GET AREXVY

See when and where you can get AREXVY.

FIND AREXVY

GET VACCINE REMINDERS

Sign up for reminders about getting AREXVY.

REMIND ME

STAY INFORMED

Sign up for more information about RSV and AREXVY.

RSV? Make it

Ask your doctor.